NATURADE INC
10-Q, EX-27, 2000-11-14
PHARMACEUTICAL PREPARATIONS
Previous: NATURADE INC, 10-Q, 2000-11-14
Next: STRATEGIA CORP, 10QSB, 2000-11-14



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                         107,557
<SECURITIES>                                         0
<RECEIVABLES>                                1,703,070
<ALLOWANCES>                                         0
<INVENTORY>                                  1,929,140
<CURRENT-ASSETS>                             4,048,593
<PP&E>                                         673,665
<DEPRECIATION>                                 391,748
<TOTAL-ASSETS>                               4,418,362
<CURRENT-LIABILITIES>                        3,766,630
<BONDS>                                              0
                                0
                                        125
<COMMON>                                           697
<OTHER-SE>                                 (4,119,869)
<TOTAL-LIABILITY-AND-EQUITY>                 4,418,362
<SALES>                                     10,898,650
<TOTAL-REVENUES>                            10,898,650
<CGS>                                        5,789,927
<TOTAL-COSTS>                                6,183,309
<OTHER-EXPENSES>                               146,204
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             520,017
<INCOME-PRETAX>                            (1,740,809)
<INCOME-TAX>                                       800
<INCOME-CONTINUING>                        (1,741,609)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (1,741,609)
<EPS-BASIC>                                     (0.25)
<EPS-DILUTED>                                   (0.25)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission